Lv7
4998 积分 2021-08-24 加入
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
8天前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
8天前
已完结
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
24天前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
24天前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
24天前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
1个月前
已完结
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
1个月前
已完结
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
1个月前
已完结
Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee
1个月前
已完结
局部晚期不可切除非小细胞肺癌放射免疫联合治疗研究进展
1个月前
已完结
皖公网安备34019202002308
